Expression of CD24 on CD19-CD79a+ early B-cell progenitors in human bone marrow

被引:15
作者
Israel, E
Kapelushnik, J
Yermiahu, T
Levi, I
Yaniv, I
Shpilberg, O
Shubinsky, G [1 ]
机构
[1] Soroka Univ, Med Ctr, Flow Cytometry Unit, Beer Sheva, Israel
[2] Soroka Univ, Med Ctr, Inst Hematol, Beer Sheva, Israel
[3] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Immunol, IL-84105 Beer Sheva, Israel
[4] Schneider Childrens Med Ctr Israel, Dept Hematol Oncol, Petah Tiqwa, Israel
关键词
early B-cell progenitors; CD24; human bone marrow; B lymphocyte maturation;
D O I
10.1016/j.cellimm.2005.08.026
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD24 is a surface marker expressed in immature and mature B cells and involved in cellular adhesion and apoptosis. There are no data, which delineate the stage in early development of human B cells, which marks the expression of CD24. We studied lymphopoiesis in normal pediatric bone marrow (BM) and found that 1.5 +/- 0.2% of WBC were CD24(+) lymphocytes which did not express CD19. A significant fraction of these cells expressed low levels of CD45 (CD19(-)CD24(+)CD45(low) cells). Small numbers of CD19(-)CD24(+)CD45(low) cells were found in the regenerating BM of children with acute lymphoblastic leukemia after the completion of chemotherapy and in normal adult BM. Flow cytometric analyses have shown that CD19(-)CD24(+)CD45(low) lymphocytes express CD10, CD34, CD79a, CD79a (VpreB), and TdT markers, i.e., displayed antigenic properties of early B-cell progenitors. Our data indicate that CD19(-) early B-cell progenitors in human BM express CD24, and that the expression of CD24 in human B-cell development precedes the expression of CD19. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 40 条
[11]   A developing picture of lymphopoiesis in bone marrow [J].
Hirose, J ;
Kouro, T ;
Igarashi, H ;
Yokota, T ;
Sakaguchi, N ;
Kincade, PW .
IMMUNOLOGICAL REVIEWS, 2002, 189 :28-40
[12]  
HOKLAND P, 1985, J IMMUNOL, V135, P1746
[13]  
Hunte BE, 1998, EUR J IMMUNOL, V28, P3850
[14]   Fate of surrogate light chains in B lineage cells [J].
Lassoued, K ;
Illges, H ;
Benlagha, K ;
Cooper, MD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :421-429
[15]  
LAVABREBERTRAND T, 1994, LEUKEMIA, V8, P402
[16]   Fates of human B-cell precursors [J].
LeBien, TW .
BLOOD, 2000, 96 (01) :9-23
[17]   The human (ΨL+μ-) proB complex:: Cell surface expression and biochemical structure of a putative transducing receptor [J].
Lemmers, B ;
Gauthier, L ;
Guelpa-Fonlupt, V ;
Fougereau, M ;
Schiff, C .
BLOOD, 1999, 93 (12) :4336-4346
[18]   Identification of the earliest B lineage stage in mouse bone marrow [J].
Li, YS ;
Wasserman, R ;
Hayakawa, K ;
Hardy, RR .
IMMUNITY, 1996, 5 (06) :527-535
[19]  
LOKEN MR, 1987, BLOOD, V70, P1316
[20]   Flow cytometric analysis of normal B cell differentiation:: a frame of reference for the detection of minimal residual disease in precursor-B-ALL [J].
Lúcio, P ;
Parreira, A ;
van den Beemd, MWM ;
van Lochem, EG ;
van Wering, ER ;
Baars, E ;
Porwit-MacDonald, A ;
Bjorklund, E ;
Gaipa, G ;
Biondi, A ;
Orfao, A ;
Janossy, G ;
van Dongen, JJM ;
San Miguel, JF .
LEUKEMIA, 1999, 13 (03) :419-427